Aino Health AB(DE:50V)
€0.01-0.02 (-61.29%)
DE:50V
Aino Health AB financials statements
€0.01
At close:-0.02 (-61.29%)
Aino Health AB (50V) Ratios
0 Followers
Aino Health AB Ratios
DE:50V's free cash flow for Q2 2026 was kr-2.03M. For the 2026 fiscal year, DE:50V's free cash flow was increased by kr0.00 and operating cash flow was kr-2.03M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.89 | 0.44 | 0.38 | 0.33 | 0.29 |
| Quick Ratio | 0.89 | 0.44 | 0.38 | 0.33 | 0.29 |
| Cash Ratio | 0.69 | 0.07 | 0.10 | 0.11 | 0.03 |
| Solvency Ratio | -0.26 | -0.67 | -0.60 | -0.67 | -0.81 |
| Operating Cash Flow Ratio | -0.29 | -0.44 | -0.44 | -0.68 | -0.53 |
| Short-Term Operating Cash Flow Coverage | -4.46 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr -8.66M | kr -5.78M | kr -8.97M | kr -13.33M | kr -11.98M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.86 | 0.02 | 0.01 | 0.04 | 0.06 |
| Debt-to-Equity Ratio | -1.30 | -0.37 | -0.19 | -0.29 | 0.41 |
| Debt-to-Capital Ratio | 4.38 | -0.59 | -0.24 | -0.42 | 0.29 |
| Long-Term Debt-to-Capital Ratio | 5.73 | 0.00 | -0.24 | -0.42 | 0.29 |
| Financial Leverage Ratio | -1.51 | -21.53 | -15.88 | -7.76 | 7.38 |
| Debt Service Coverage Ratio | -2.35 | -7.86 | -6.88 | -15.90 | -10.28 |
| Interest Coverage Ratio | -6.08 | -11.64 | -8.69 | -18.29 | -10.89 |
| Debt to Market Cap | 0.24 | 0.00 | 0.01 | 0.01 | 0.08 |
| Interest Debt Per Share | 0.04 | 0.01 | 0.02 | 0.03 | 0.08 |
| Net Debt to EBITDA | -0.77 | 0.09 | 0.17 | 0.12 | -0.05 |
| Profitability Margins | |||||
| Gross Profit Margin | -16.36% | 89.83% | 15.88% | 89.27% | 93.56% |
| EBIT Margin | -20.05% | -38.42% | -39.99% | -71.16% | -60.40% |
| EBITDA Margin | -12.60% | -25.94% | -31.48% | -61.56% | -52.44% |
| Operating Profit Margin | -20.05% | -38.42% | -39.77% | -73.12% | -61.53% |
| Pretax Profit Margin | -23.40% | -41.41% | -44.57% | -75.16% | -66.05% |
| Net Profit Margin | -23.40% | -41.41% | -44.57% | -75.16% | -66.05% |
| Continuous Operations Profit Margin | -23.40% | -41.41% | -44.57% | -75.16% | -66.05% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 116.73% | 107.80% | 112.07% | 102.78% | 107.35% |
| Return on Assets (ROA) | -63.01% | -100.54% | -78.89% | -86.32% | -80.03% |
| Return on Equity (ROE) | 95.14% | 2164.85% | 1252.76% | 669.74% | -590.61% |
| Return on Capital Employed (ROCE) | -390.96% | 2008.30% | 1384.72% | 924.25% | -389.72% |
| Return on Invested Capital (ROIC) | -278.46% | 2008.30% | 1384.72% | 924.25% | -389.72% |
| Return on Tangible Assets | -80.83% | -212.45% | -192.51% | -232.47% | -255.28% |
| Earnings Yield | -17.47% | -28.81% | -47.42% | -30.43% | -110.51% |
| Efficiency Ratios | |||||
| Receivables Turnover | 15.59 | 6.39 | 7.23 | 4.98 | 5.84 |
| Payables Turnover | 13.22 | 1.49 | 12.58 | 1.21 | 0.80 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 483.56 | 310.92 | 241.61 | 128.44 | 121.28 |
| Asset Turnover | 2.69 | 2.43 | 1.77 | 1.15 | 1.21 |
| Working Capital Turnover Ratio | -7.82 | -3.28 | -2.23 | -1.69 | -4.36 |
| Cash Conversion Cycle | -4.19 | -187.43 | 21.49 | -227.28 | -393.09 |
| Days of Sales Outstanding | 23.41 | 57.16 | 50.51 | 73.30 | 62.49 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 27.61 | 244.58 | 29.02 | 300.58 | 455.57 |
| Operating Cycle | 23.41 | 57.16 | 50.51 | 73.30 | 62.49 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.03 | -0.08 | -0.27 | -0.26 |
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.08 | -0.27 | -0.26 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.29 | -26.75 | -38.18 | -19.53 | -7.65 |
| Operating Cash Flow to Sales Ratio | -0.09 | -0.19 | -0.26 | -0.65 | -0.35 |
| Free Cash Flow Yield | -6.90% | -13.21% | -27.85% | -26.18% | -58.91% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.72 | -3.47 | -2.11 | -3.29 | -0.90 |
| Price-to-Sales (P/S) Ratio | 1.34 | 1.44 | 0.94 | 2.47 | 0.60 |
| Price-to-Book (P/B) Ratio | -5.45 | -75.15 | -26.42 | -22.01 | 5.34 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -14.49 | -7.57 | -3.59 | -3.82 | -1.70 |
| Price-to-Operating Cash Flow Ratio | -14.49 | -7.57 | -3.59 | -3.82 | -1.70 |
| Price-to-Earnings Growth (PEG) Ratio | 0.10 | 0.07 | 0.03 | 0.08 | 0.09 |
| Enterprise Value Multiple | -11.40 | -5.45 | -2.82 | -3.89 | -1.19 |
| Enterprise Value | 37.50M | 33.85M | 21.21M | 47.67M | 14.38M |
| EV to EBITDA | -11.40 | -5.45 | -2.82 | -3.89 | -1.19 |
| EV to Sales | 1.44 | 1.41 | 0.89 | 2.39 | 0.62 |
| EV to Free Cash Flow | -15.53 | -7.44 | -3.39 | -3.70 | -1.77 |
| EV to Operating Cash Flow | -15.53 | -7.44 | -3.39 | -3.70 | -1.77 |
| Tangible Book Value Per Share | -0.04 | -0.04 | -0.11 | -0.28 | -0.34 |
| Shareholders’ Equity Per Share | -0.03 | -0.00 | -0.01 | -0.05 | 0.08 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.03 | -0.09 |
| Revenue Per Share | 0.13 | 0.17 | 0.29 | 0.42 | 0.75 |
| Net Income Per Share | -0.03 | -0.07 | -0.13 | -0.32 | -0.49 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.17 | 1.08 | 1.11 | 1.06 | 1.09 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.04 | 0.05 | 0.04 |
| SG&A to Revenue | 0.00 | 0.43 | 0.00 | 0.00 | 0.57 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.40 | 0.49 | 0.66 | 0.89 | 0.57 |
Currency in SEK
